Gilead Sciences, Inc.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada,…
Drug Manufacturers - General
US, Foster City [HQ]
GILD/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,011.00 | 7,949.00 | 8,385.00 | 9,702.00 | 11,201.00 | 24,890.00 | 32,639.00 | 30,390.00 | 26,107.00 | 22,127.00 | 22,449.00 | 24,689.00 | 27,305.00 | 27,281.00 | 27,116.00 | |
|
EPS
|
1.46 | 1.70 | 1.81 | 1.71 | 2.01 | 7.95 | 12.37 | 10.08 | 3.54 | 4.20 | 4.24 | 0.07 | 4.96 | 3.66 | 4.54 | |
| Diluted in mil. | 1.41 | 1.66 | 1.78 | 1.64 | 1.81 | 7.35 | 11.91 | 9.94 | 3.51 | 4.17 | 4.22 | 0.07 | 4.93 | 3.64 | 4.50 | |
|
Profit
|
5,415.00 | 6,079.00 | 6,260.00 | 7,231.00 | 8,343.00 | 21,102.00 | 28,633.00 | 26,129.00 | 21,736.00 | 17,274.00 | 17,774.00 | 20,117.00 | 20,704.00 | 21,624.00 | 21,148.00 | |
| Gross Margin | 77.24 | 76.48 | 74.67 | 74.53 | 74.48 | 84.78 | 87.73 | 85.98 | 83.26 | 78.07 | 79.18 | 81.48 | 75.82 | 79.26 | 77.99 | |
| Pre Tax | 3,501.00 | 3,913.00 | 3,651.00 | 3,611.00 | 4,208.00 | 14,856.00 | 21,659.00 | 17,097.00 | 13,529.00 | 7,799.00 | 5,160.00 | 1,669.00 | 8,278.00 | 5,814.00 | 6,859.00 | |
| Profit Margin | 49.95 | 49.23 | 43.54 | 37.23 | 37.57 | 59.69 | 66.36 | 56.26 | 51.82 | 35.25 | 22.99 | 6.76 | 30.32 | 21.31 | 25.30 | |
| ETR | 25.02 | 26.16 | 23.61 | 28.75 | 27.35 | 18.83 | 16.40 | 21.11 | 65.67 | 29.99 | -3.95 | 94.67 | 25.09 | 21.47 | 18.18 | |
| Net | 2,635.00 | 2,901.00 | 2,803.00 | 2,591.00 | 3,074.00 | 12,101.00 | 18,108.00 | 13,501.00 | 4,628.00 | 5,455.00 | 5,386.00 | 89.00 | 6,225.00 | 4,592.00 | 5,665.00 | |
| Profit Margin | 37.59 | 36.50 | 33.43 | 26.71 | 27.45 | 48.62 | 55.48 | 44.43 | 17.73 | 24.65 | 23.99 | 0.36 | 22.80 | 16.83 | 20.89 | |
| EBITDA | 3,571.00 | 4,022.00 | 3,856.00 | 3,972.00 | 4,515.00 | 15,268.00 | 22,347.00 | 18,061.00 | 14,647.00 | 8,876.00 | 6,155.00 | 8,509.00 | 9,456.00 | 10,393.00 | 11,701.00 | |
| EBITDA Margin | 50.94 | 50.60 | 45.99 | 40.95 | 40.31 | 61.34 | 68.47 | 59.43 | 56.10 | 40.11 | 27.42 | 34.46 | 34.63 | 38.10 | 43.15 | |
| Operating Income | 3,529.00 | 3,962.00 | 3,789.00 | 4,010.00 | 4,523.00 | 15,265.00 | 22,193.00 | 17,633.00 | 14,124.00 | 8,200.00 | 4,287.00 | 7,029.00 | 7,406.00 | 7,330.00 | 9,368.00 | |
| Operating Margin | 50.34 | 49.84 | 45.20 | 41.33 | 40.39 | 61.33 | 68.00 | 58.02 | 54.10 | 37.06 | 19.10 | 28.47 | 27.12 | 26.87 | 34.55 | |
| Interest Income | 42.00 | 60.00 | 66.00 | - - | - - | - - | - - | - - | - - | - - | 995.00 | 984.00 | 1,001.00 | 935.00 | 376.00 | |
| Loss | -3,482.00 | -3,987.00 | -4,595.00 | -5,692.00 | -6,677.00 | -9,625.00 | -10,446.00 | -12,757.00 | -11,983.00 | -13,927.00 | -18,162.00 | -14,762.00 | -17,210.00 | -16,307.00 | -17,748.00 | |
| Cost of Revenue | -1,595.00 | -1,869.00 | -2,124.00 | -2,471.00 | -2,858.00 | -3,788.00 | -4,006.00 | -4,261.00 | -4,371.00 | -4,853.00 | -4,675.00 | -4,572.00 | -6,601.00 | -5,657.00 | -5,968.00 | |
|
Operating Expenses
|
-1,886.00 | -2,117.00 | -2,471.00 | -3,220.00 | -3,819.00 | -5,837.00 | -6,440.00 | -8,496.00 | -7,612.00 | -9,074.00 | -13,487.00 | -10,190.00 | -10,609.00 | -10,650.00 | -11,780.00 | |
| R&D | -939.00 | -1,072.00 | -1,229.00 | -1,759.00 | -2,119.00 | -2,854.00 | -3,014.00 | -5,098.00 | -3,734.00 | -5,018.00 | -9,106.00 | -5,039.00 | -5,363.00 | -4,977.00 | -5,720.00 | |
| G&A | -946.00 | -1,044.00 | -1,241.00 | -1,461.00 | -1,699.00 | -2,983.00 | -3,426.00 | -3,398.00 | -3,878.00 | -4,056.00 | -3,597.00 | -4,356.00 | -4,511.00 | -4,895.00 | -5,234.00 | |
| SG&A | -946.00 | -1,044.00 | -1,241.00 | -1,461.00 | -1,699.00 | -2,983.00 | -3,426.00 | -3,398.00 | -3,878.00 | -4,056.00 | -4,381.00 | -5,151.00 | -5,246.00 | -5,673.00 | -6,060.00 | |
| S&M | - - | - - | - - | -160.00 | -216.00 | -393.00 | -601.00 | -618.00 | -600.00 | -587.00 | -784.00 | -795.00 | -735.00 | -778.00 | -826.00 | |
| Depreciation and Amortization | -212.00 | -265.00 | -302.00 | -278.00 | -344.00 | -1,050.00 | -1,098.00 | -1,158.00 | -1,286.00 | -1,429.00 | -1,404.00 | -1,480.00 | -2,050.00 | -2,103.00 | -2,693.00 | |
| Interest Expenses | -69.00 | -108.00 | -205.00 | -360.00 | -306.00 | -412.00 | -688.00 | -964.00 | -1,118.00 | -1,077.00 | -995.00 | -984.00 | -1,001.00 | -935.00 | -944.00 | |
| Other Expenses | -27.00 | -48.00 | -138.00 | -37.00 | -8.00 | -3.00 | -154.00 | -428.00 | -523.00 | -676.00 | -873.00 | -5,360.00 | -872.00 | -1,516.00 | -2,509.00 | |
|
WA Shares Outstanding
|
1,809.00 | 1,712.00 | 1,549.00 | 1,514.00 | 1,528.00 | 1,522.00 | 1,464.00 | 1,339.00 | 1,307.00 | 1,298.00 | 1,270.00 | 1,257.00 | 1,256.00 | 1,255.00 | 1,248.00 | |
| Diluted | 1,868.00 | 1,746.00 | 1,580.00 | 1,582.00 | 1,694.00 | 1,647.00 | 1,521.00 | 1,358.00 | 1,319.00 | 1,308.00 | 1,277.00 | 1,263.00 | 1,262.00 | 1,262.00 | 1,258.00 |